サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1672119

がん免疫療法創薬アウトソーシングの世界市場調査レポート：産業分析、規模、シェア、成長、動向、2025年から2033年までの予測

Global Cancer Immunotherapy Drug Discovery Outsourcing Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日
ページ情報
英文 130 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
がん免疫療法創薬アウトソーシングの世界市場調査レポート：産業分析、規模、シェア、成長、動向、2025年から2033年までの予測
出版日: 2025年03月01日
発行: Value Market Research
ページ情報: 英文 130 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

がん免疫療法創薬アウトソーシングの世界市場規模は、2024年の20億9,000万米ドルから2033年には50億8,000万米ドルに成長し、2026年から2033年の予測期間中に10.42％の堅調な年間平均成長率（CAGR）を示すと予測されます。

がん免疫療法の創薬アウトソーシング市場は、革新的ながん治療に対する需要の高まりと医薬品開発プロセスの複雑化に牽引され、大きな成長が見込まれています。免疫療法は、がん細胞を標的として破壊するために身体の免疫システムを利用する、がん治療の有望なアプローチとして浮上してきました。製薬企業が創薬活動の迅速化とコスト削減を目指す中、免疫療法の研究開発活動のアウトソーシングが一般的になりつつあり、この市場は堅調な拡大が見込まれています。

さらに、免疫療法技術の進歩が市場のイノベーションを促進しています。モノクローナル抗体、CAR-T細胞療法、免疫チェックポイント阻害剤などの新規治療薬の開発は、がん治療に革命をもたらし、アウトソーシング・パートナーシップの新たな機会を生み出しています。こうした技術革新はがん治療の有効性を高めるだけでなく、専門的な知識やリソースを必要とするため、アウトソーシングは多くの組織にとって魅力的な選択肢となっています。新たな免疫療法アプローチや併用療法の研究が進むにつれ、がん免疫療法の創薬アウトソーシング市場は、患者予後の改善や医薬品開発期間の短縮が期待できることから、さらに拡大するとみられます。

さらに、共同研究や戦略的パートナーシップを重視する動きが強まっていることも、がん免疫療法創薬アウトソーシング市場を形成しています。利害関係者が外部の専門知識やリソースを活用することの価値を認識するにつれ、製薬企業と医薬品開発業務受託機関（CRO）との提携がより一般的になりつつあります。このような提携により、企業は創薬パイプラインを強化するための専門知識、高度な技術、効率的なプロセスを利用することができます。がん免疫療法の創薬アウトソーシング市場が進化を続ける中、コラボレーションとイノベーションへの注力は今後の成長を牽引する重要な役割を果たすと思われます。

当社のレポートは、様々な業界や市場に関する包括的かつ実用的な洞察をお客様に提供するために綿密に作成されています。各レポートは、市場情勢を完全に理解するために、いくつかの重要な要素を含んでいます：

市場概要：市場概要：定義、分類、業界の現状など、市場に関する詳細なイントロダクション

市場促進要因：市場成長に影響を与える主な促進要因・抑制要因・市場促進要因・課題を詳細に分析します。このセクションでは、技術の進歩、規制の変更、新たな動向などの要因を検証します。

セグメンテーション分析：製品タイプ、用途、エンドユーザー、地域などの基準に基づき、市場を明確なセグメントに内訳。この分析により、各セグメントの業績と将来性を明らかにします。

競合情勢：市場シェア、製品ポートフォリオ、戦略的イニシアティブ、財務実績など、主要市場プレイヤーの包括的評価。主要企業が採用する競合力学と主要戦略に関する考察を提供します。

市場予測：過去のデータと現在の市場状況に基づき、一定期間における市場規模と成長動向を予測します。これには、定量的分析と将来の市場軌跡を示すグラフ表示が含まれます。

地域分析：地域ごとの市場パフォーマンスを評価し、主要市場や地域動向を明らかにします。地域の市場力学とビジネスチャンスを理解するのに役立ちます。

新たな動向と機会：現在の市場動向と新たな市場動向、技術革新、潜在的な投資対象分野を特定します。将来の市場開拓と成長見通しに関する洞察を提供します。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 がん免疫療法創薬アウトソーシング業界分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 がん免疫療法創薬アウトソーシングの世界市場分析：サービスタイプ別

  • サービスタイプ別、概要
  • サービスタイプ別、過去および予測データ分析
  • ターゲット同定とバリデーション
  • リード化合物のスクリーニングと特性評価
  • セルベースアッセイ

第6章 がん免疫療法創薬アウトソーシングの世界市場分析：がんタイプ別

  • がんタイプ別、概要
  • がんタイプ別、過去および予測データ分析
  • 肺がん
  • 乳がん
  • 大腸がん
  • 黒色腫がん
  • 前立腺がん
  • 頭頸部がん
  • 卵巣がん
  • 膵臓がん

第7章 がん免疫療法創薬アウトソーシングの世界市場分析：薬剤タイプ別

  • 薬剤タイプ別、概要
  • 薬剤タイプ別、過去および予測データ分析
  • モノクローナル抗体
  • 免疫調節薬
  • がんワクチン、およびがん溶解性ウイルス療法
  • その他

第8章 がん免疫療法創薬アウトソーシングの世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋地域売上分析
    • 概要、実績と予測
    • アジア太平洋地域：セグメント別
    • アジア太平洋地域国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他アジア太平洋地域
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ国別一覧
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東とアフリカ

第9章 がん免疫療法創薬アウトソーシング企業の競合情勢

  • がん免疫療法創薬アウトソーシング市場の競合
  • パートナーシップ/提携/合意
  • 合併・買収
  • 新製品の発売
  • その他の開発

第10章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Covance Inc.
  • Explicyte
  • Aquila BioMedical
  • Horizon Discovery Group PLC
  • Crown Bioscience Inc.
  • Promega Corporation
  • HD Biosciences Co. Ltd.
  • BPS Bioscience Inc.
  • Genscript Biotech Corporation
  • DiscoverX Corporation
  • Celentyx Ltd.
  • ImmunXperts SA
  • Personalis Inc.
  • STC Biologics
  • Molecular Imaging Inc
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Service Type (USD MN)
  • Target Identification and Validation Market Sales By Geography (USD MN)
  • Lead Screening and Characterization Market Sales By Geography (USD MN)
  • Cell-based Assays Market Sales By Geography (USD MN)
  • Analysis By Cancer Type (USD MN)
  • Lung Market Sales By Geography (USD MN)
  • Breast Market Sales By Geography (USD MN)
  • Colorectal Market Sales By Geography (USD MN)
  • Melanoma Market Sales By Geography (USD MN)
  • Prostate Market Sales By Geography (USD MN)
  • Head and Neck Market Sales By Geography (USD MN)
  • Ovarian Market Sales By Geography (USD MN)
  • Pancreatic Market Sales By Geography (USD MN)
  • Analysis By Drug Type (USD MN)
  • Monoclonal Antibodies Market Sales By Geography (USD MN)
  • Immunomodulators Market Sales By Geography (USD MN)
  • Cancer Vaccines and Oncolytic Viral Therapy Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Cancer Immunotherapy Drug Discovery Outsourcing Report
  • Market Research Process
  • Market Research Methodology
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Service Type
  • Market Attractiveness Analysis By Cancer Type
  • Market Attractiveness Analysis By Drug Type
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Service Type (USD MN)
  • Target Identification and Validation Market Sales By Geography (USD MN)
  • Lead Screening and Characterization Market Sales By Geography (USD MN)
  • Cell-based Assays Market Sales By Geography (USD MN)
  • Global Market Analysis By Cancer Type (USD MN)
  • Lung Market Sales By Geography (USD MN)
  • Breast Market Sales By Geography (USD MN)
  • Colorectal Market Sales By Geography (USD MN)
  • Melanoma Market Sales By Geography (USD MN)
  • Prostate Market Sales By Geography (USD MN)
  • Head and Neck Market Sales By Geography (USD MN)
  • Ovarian Market Sales By Geography (USD MN)
  • Pancreatic Market Sales By Geography (USD MN)
  • Global Market Analysis By Drug Type (USD MN)
  • Monoclonal Antibodies Market Sales By Geography (USD MN)
  • Immunomodulators Market Sales By Geography (USD MN)
  • Cancer Vaccines and Oncolytic Viral Therapy Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
目次
Product Code: VMR11211227

Global Cancer Immunotherapy Drug Discovery Outsourcing Market size is anticipated to grow from USD 2.09 Billion in 2024 to USD 5.08 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 10.42% during the forecast period of 2026 to 2033.

The cancer immunotherapy drug discovery outsourcing market is poised for significant growth, driven by the increasing demand for innovative cancer treatments and the rising complexity of drug development processes. Immunotherapy has emerged as a promising approach to cancer treatment, harnessing the body's immune system to target and destroy cancer cells. As pharmaceutical companies seek to accelerate their drug discovery efforts and reduce costs, the outsourcing of immunotherapy research and development activities is becoming increasingly common, positioning this market for robust expansion.

Moreover, advancements in immunotherapy technologies are driving innovation within the market. The development of novel therapeutic agents, such as monoclonal antibodies, CAR-T cell therapies, and immune checkpoint inhibitors, is revolutionizing cancer treatment and creating new opportunities for outsourcing partnerships. These innovations not only enhance the efficacy of cancer therapies but also require specialized expertise and resources, making outsourcing an attractive option for many organizations. As research continues to explore new immunotherapeutic approaches and combination therapies, the cancer immunotherapy drug discovery outsourcing market is likely to expand further, driven by the promise of improved patient outcomes and accelerated drug development timelines.

Additionally, the growing emphasis on collaboration and strategic partnerships is shaping the cancer immunotherapy drug discovery outsourcing landscape. As stakeholders recognize the value of leveraging external expertise and resources, the formation of alliances between pharmaceutical companies and contract research organizations (CROs) is becoming more prevalent. These partnerships enable companies to access specialized knowledge, advanced technologies, and efficient processes that can enhance the drug discovery pipeline. As the cancer immunotherapy drug discovery outsourcing market continues to evolve, the focus on collaboration and innovation will play a crucial role in driving its future growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Service Type

  • Target Identification and Validation
  • Lead Screening and Characterization
  • Cell-based Assays

By Cancer Type

  • Lung
  • Breast
  • Colorectal
  • Melanoma
  • Prostate
  • Head and Neck
  • Ovarian
  • Pancreatic

By Drug Type

  • Monoclonal Antibodies
  • Immunomodulators
  • Cancer Vaccines and Oncolytic Viral Therapy
  • Others
  • COMPANIES PROFILED
  • Covance Inc.
  • Explicyte
  • Aquila BioMedical
  • Horizon Discovery Group PLC
  • Crown Bioscience Inc.
  • Promega Corporation
  • HD Biosciences Co. Ltd.
  • BPS Bioscience Inc.
  • Genscript Biotech Corporation
  • DiscoverX Corporation
  • Celentyx Ltd.
  • ImmunXperts SA
  • Personalis Inc.
  • STC Biologics
  • Molecular Imaging Inc.
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porters Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Service Type
    • 3.7.2 Market Attractiveness Analysis By Cancer Type
    • 3.7.3 Market Attractiveness Analysis By Drug Type
    • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING MARKET ANALYSIS BY SERVICE TYPE

  • 5.1. Overview By Service Type
  • 5.2. Historical and Forecast Data Analysis By Service Type
  • 5.3. Target Identification and Validation Historic and Forecast Sales By Regions
  • 5.4. Lead Screening and Characterization Historic and Forecast Sales By Regions
  • 5.5. Cell-based Assays Historic and Forecast Sales By Regions

6. GLOBAL CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING MARKET ANALYSIS BY CANCER TYPE

  • 6.1. Overview By Cancer Type
  • 6.2. Historical and Forecast Data Analysis By Cancer Type
  • 6.3. Lung Historic and Forecast Sales By Regions
  • 6.4. Breast Historic and Forecast Sales By Regions
  • 6.5. Colorectal Historic and Forecast Sales By Regions
  • 6.6. Melanoma Historic and Forecast Sales By Regions
  • 6.7. Prostate Historic and Forecast Sales By Regions
  • 6.8. Head and Neck Historic and Forecast Sales By Regions
  • 6.9. Ovarian Historic and Forecast Sales By Regions
  • 6.10. Pancreatic Historic and Forecast Sales By Regions

7. GLOBAL CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING MARKET ANALYSIS BY DRUG TYPE

  • 7.1. Overview By Drug Type
  • 7.2. Historical and Forecast Data Analysis By Drug Type
  • 7.3. Monoclonal Antibodies Historic and Forecast Sales By Regions
  • 7.4. Immunomodulators Historic and Forecast Sales By Regions
  • 7.5. Cancer Vaccines and Oncolytic Viral Therapy Historic and Forecast Sales By Regions
  • 7.6. Others Historic and Forecast Sales By Regions

8. GLOBAL CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING COMPANIES

  • 9.1. Cancer Immunotherapy Drug Discovery Outsourcing Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Covance Inc.
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. Explicyte
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. Aquila BioMedical
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. Horizon Discovery Group PLC
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. Crown Bioscience Inc.
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. Promega Corporation
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. HD Biosciences Co. Ltd.
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. BPS Bioscience Inc.
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments
  • 10.11. Genscript Biotech Corporation
    • 10.11.1 Company Overview
    • 10.11.2 Company Revenue
    • 10.11.3 Products
    • 10.11.4 Recent Developments
  • 10.12. DiscoverX Corporation
    • 10.12.1 Company Overview
    • 10.12.2 Company Revenue
    • 10.12.3 Products
    • 10.12.4 Recent Developments
  • 10.13. Celentyx Ltd.
    • 10.13.1 Company Overview
    • 10.13.2 Company Revenue
    • 10.13.3 Products
    • 10.13.4 Recent Developments
  • 10.14. ImmunXperts SA
    • 10.14.1 Company Overview
    • 10.14.2 Company Revenue
    • 10.14.3 Products
    • 10.14.4 Recent Developments
  • 10.15. Personalis Inc.
    • 10.15.1 Company Overview
    • 10.15.2 Company Revenue
    • 10.15.3 Products
    • 10.15.4 Recent Developments
  • 10.16. STC Biologics
    • 10.16.1 Company Overview
    • 10.16.2 Company Revenue
    • 10.16.3 Products
    • 10.16.4 Recent Developments
  • 10.17. Molecular Imaging Inc
    • 10.17.1 Company Overview
    • 10.17.2 Company Revenue
    • 10.17.3 Products
    • 10.17.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies